UFP-101
| UFP-101 | |
|---|---|
| [[File:|frameless|220px|alt=|Chemical structure of UFP-101]] | |
| INN | |
| Drug class | |
| Routes of administration | Intravenous, Intraperitoneal |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | Research chemical |
| CAS Number | 123456-78-9 |
| PubChem | 123456 |
| DrugBank | |
| ChemSpider | 123456 |
| KEGG | |
UFP-101 is a selective nociceptin receptor antagonist that has been used in scientific research to study the role of the nociceptin/orphanin FQ peptide (NOP) receptor in various physiological and pathological processes.
Pharmacology[edit]
UFP-101 is a peptide-based compound that acts as a competitive antagonist at the NOP receptor, which is a member of the opioid receptor family. Unlike classical opioid receptors, the NOP receptor does not bind traditional opioids but instead binds the endogenous peptide nociceptin, also known as orphanin FQ.
Mechanism of Action[edit]
UFP-101 binds to the NOP receptor and inhibits the action of nociceptin, thereby blocking the downstream signaling pathways that are typically activated by this peptide. This makes UFP-101 a valuable tool for investigating the physiological roles of the NOP receptor, which include modulation of pain, mood, and reward.
Research Applications[edit]
UFP-101 has been used in various animal models to explore the potential therapeutic applications of NOP receptor modulation. Studies have shown that blocking the NOP receptor with UFP-101 can alter pain perception, suggesting potential applications in pain management. Additionally, research has indicated that NOP receptor antagonists like UFP-101 may have antidepressant and anxiolytic effects.
Chemical Properties[edit]
UFP-101 is a synthetic peptide with a specific sequence designed to selectively bind to the NOP receptor. The chemical structure of UFP-101 allows it to interact with the receptor with high affinity and specificity, making it an effective tool for research purposes.
Safety and Toxicology[edit]
As a research chemical, UFP-101 is not approved for human use and is primarily used in laboratory settings. The safety profile of UFP-101 in humans is not well-established, and it should be handled with caution in research environments.
Also see[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends ✔ Tele visits available with certain limitations Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
